Non-hodgkins lymphoma

Clin Evid. 2003 Jun:(9):1-21.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Bleomycin / administration & dosage
  • Carmustine / administration & dosage
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Doxorubicin / analogs & derivatives
  • Etoposide / administration & dosage
  • Humans
  • Idarubicin / administration & dosage
  • Ifosfamide / administration & dosage
  • Leucovorin / administration & dosage
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Lymphoma, Non-Hodgkin / radiotherapy
  • Lymphoma, Non-Hodgkin / therapy
  • Methotrexate / administration & dosage
  • Prednisolone / administration & dosage
  • Prednisone / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Cytarabine
  • Bleomycin
  • Vincristine
  • Etoposide
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Cisplatin
  • Leucovorin
  • Carmustine
  • Ifosfamide
  • Prednisone
  • Methotrexate
  • Idarubicin

Supplementary concepts

  • BCVP protocol
  • CHOP protocol
  • CHOP protocol, modified
  • CIOP protocol
  • HOP protocol
  • M-BACOD protocol
  • MACOP-B protocol
  • MEV protocol
  • PACE-BOM protocol
  • PROMACE-CytaBOM protocol